These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24332387)

  • 1. Association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine.
    Kim JH; Lee J; Kim YB; Han AY
    Compr Psychiatry; 2014 Apr; 55(3):708-13. PubMed ID: 24332387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics.
    Kim JH; Ann JH; Kim MJ
    J Clin Pharm Ther; 2011 Apr; 36(2):172-8. PubMed ID: 21366646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
    Gross A; Joutsiniemi SL; Rimon R; Appelberg B
    Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.
    Mitsonis CI; Dimopoulos NP; Mitropoulos PA; Kararizou EG; Katsa AN; Tsakiris FE; Katsanou MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):373-7. PubMed ID: 17092620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG; Thornton AE; Chen EY; Chan RC; Wong JO; Bergmann A; Falkai P; Pomarol-Clotet E; McKenna PJ; Stip E; Williams R; MacEwan GW; Wasan K; Procyshyn R;
    N Engl J Med; 2006 Feb; 354(5):472-82. PubMed ID: 16452559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
    Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia.
    Shang DW; Li LJ; Wang XP; Wen YG; Ren YP; Guo W; Li WB; Li L; Zhou TY; Lu W; Wang CY
    Ther Drug Monit; 2014 Jun; 36(3):378-86. PubMed ID: 24342896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].
    Reine G; Bernard D; Auquier P; Le Fur B; Lançon C
    Encephale; 2000; 26(1):52-61. PubMed ID: 10875062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
    Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.